Not applicableStudy completedNCT04279470
What this trial is testing
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
Who this might be right for
Adverse Drug ReactionsCancer
Groupe Hospitalier Pitie-Salpetriere 100,000